SG10202007206WA - Improved harvest operations for recombinant proteins - Google Patents

Improved harvest operations for recombinant proteins

Info

Publication number
SG10202007206WA
SG10202007206WA SG10202007206WA SG10202007206WA SG10202007206WA SG 10202007206W A SG10202007206W A SG 10202007206WA SG 10202007206W A SG10202007206W A SG 10202007206WA SG 10202007206W A SG10202007206W A SG 10202007206WA SG 10202007206W A SG10202007206W A SG 10202007206WA
Authority
SG
Singapore
Prior art keywords
recombinant proteins
harvest operations
improved harvest
improved
operations
Prior art date
Application number
SG10202007206WA
Other languages
English (en)
Inventor
Michael W Laird
John Richard St
Jane V Gunson
Kim Kaleas
Deepa Nadarajah
Rachel Adams
Bradley R Snedecor
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG10202007206WA publication Critical patent/SG10202007206WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/42Means for regulation, monitoring, measurement or control, e.g. flow regulation of agitation speed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Sustainable Development (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10202007206WA 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins SG10202007206WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261616297P 2012-03-27 2012-03-27

Publications (1)

Publication Number Publication Date
SG10202007206WA true SG10202007206WA (en) 2020-08-28

Family

ID=48040433

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10202007206WA SG10202007206WA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10201508420VA SG10201508420VA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG11201406112TA SG11201406112TA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10201912877SA SG10201912877SA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG10201508420VA SG10201508420VA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG11201406112TA SG11201406112TA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10201912877SA SG10201912877SA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins

Country Status (20)

Country Link
US (9) US20140080180A1 (enExample)
EP (1) EP2831261B1 (enExample)
JP (4) JP6225162B2 (enExample)
KR (2) KR20200037425A (enExample)
CN (2) CN109880867A (enExample)
AR (2) AR090340A1 (enExample)
AU (3) AU2013240280A1 (enExample)
BR (1) BR112014023176B1 (enExample)
CA (2) CA3086730A1 (enExample)
ES (1) ES2654424T3 (enExample)
HR (1) HRP20171966T1 (enExample)
IL (1) IL234377B (enExample)
MX (3) MX365947B (enExample)
MY (1) MY171729A (enExample)
PL (1) PL2831261T3 (enExample)
RU (2) RU2017139267A (enExample)
SG (4) SG10202007206WA (enExample)
SI (1) SI2831261T1 (enExample)
WO (1) WO2013148249A1 (enExample)
ZA (1) ZA201406434B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201037B1 (en) 1986-01-28 2001-03-13 Ophthalmic Research Group International, Inc. Plastic lens composition and method for the production thereof
EP3469091A1 (en) 2016-06-10 2019-04-17 Lonza Ltd Method for stabilizing proteins
SG11201903605TA (en) * 2016-11-07 2019-05-30 Seattle Genetics Inc Distribution of engineered-cysteine caps
KR102825164B1 (ko) * 2018-03-27 2025-06-26 브리스톨-마이어스 스큅 컴퍼니 자외선 신호를 사용한 단백질 농도의 실시간 모니터링
PL3857237T3 (pl) * 2019-01-16 2023-07-10 Regeneron Pharmaceuticals, Inc. Sposoby charakteryzowania mostka disiarczkowego
CN109725088B (zh) * 2019-03-16 2021-05-18 丁立平 一种测定豆芽中2-萘甲酸及其衍生物的气相色谱-质谱联用法
CN110305903B (zh) * 2019-07-31 2021-10-01 江苏璟泽生物医药有限公司 重组人促卵泡激素及其制备方法
CN113155776A (zh) * 2021-04-29 2021-07-23 华东交通大学 一种柑桔最佳采收期预测方法
FR3146146A1 (fr) 2023-02-24 2024-08-30 Bgene Genetics Production d’acide 1-4-dihydroxy-2-naphtoïque par Escherichia coli

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2036891B (en) 1978-12-05 1983-05-05 Windsor Smith C Change speed gear
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
EP0247091B1 (en) 1985-11-01 1993-09-29 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989012463A1 (en) 1988-06-21 1989-12-28 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DK0602126T3 (da) 1991-08-14 2003-06-16 Genentech Inc Immunoglobulinvarianter til specifikke FC epsilon-receptorer
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
EP0656064B1 (en) 1992-08-17 1997-03-05 Genentech, Inc. Bispecific immunoadhesins
AU687755B2 (en) 1992-08-21 1998-03-05 Genentech Inc. Method for treating an LFA-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
EP0733207B1 (en) 1993-12-10 1997-08-27 Genentech, Inc. Methods for diagnosis of allergy and screening of anti-allergy therapeutics
JP3825798B2 (ja) 1994-01-18 2006-09-27 ジェネンテク,インコーポレイテッド IgEアンタゴニストを用いる寄生虫感染症の治療法
US5702946A (en) 1994-03-03 1997-12-30 Genentech, Inc. Anti-IL-8 monoclonal antibodies for treatment of inflammatory disorders
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
JPH11507535A (ja) 1995-06-07 1999-07-06 イムクローン システムズ インコーポレイテッド 腫瘍の成長を抑制する抗体および抗体フラグメント類
ES2183131T3 (es) 1996-01-23 2003-03-16 Genentech Inc Anticuerpos anti-cd18 utilizados contra el ictus cerebral.
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
DK0941344T3 (da) 1996-11-27 2004-09-27 Genentech Inc Humaniserede anti-CD11a-antistoffer
IL132240A0 (en) 1997-04-07 2001-03-19 Genentech Inc Anti-vegf antibodies
EP1860187B1 (en) 1997-05-15 2011-07-13 Genentech, Inc. Apo-2 receptor
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
BR0015224A (pt) 1999-10-29 2002-07-09 Genentech Inc Anticorpo anti-antìgeno de célula estaminal prostática (psca) isolado, anticorpo monoclonal anti-psca, ácido nucleico isolado, vetor de expressão, célula, célula hospedeira, método de produção de anticorpo, composição método in vitro para matar uma célula cancerosa que expresse psca, uso de uma anticorpo monoclonal anti-psca e artigo industrializado
US6946271B2 (en) * 2000-09-20 2005-09-20 Degussa Ag Nucleotide sequences which code for the menE gene
US6979556B2 (en) 2000-12-14 2005-12-27 Genentech, Inc. Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
EP1944320A1 (en) 2002-12-16 2008-07-16 Genentech, Inc. Immunoglobulin variants and uses thereof
NZ543200A (en) * 2003-03-26 2009-01-31 Meiji Dairies Corp Method for stabilizing 1,4-dihydroxy-2-naphthoic acid
ATE353969T1 (de) * 2003-08-13 2007-03-15 Sandoz Ag Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
JP4972412B2 (ja) * 2004-02-04 2012-07-11 メルク・シャープ・エンド・ドーム・コーポレイション E.コリ発酵によるプラスミドdnaの大規模生産のための方法
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
CN101115832A (zh) * 2004-11-26 2008-01-30 协和发酵工业株式会社 工业上有用的微生物
MX2008014150A (es) * 2006-05-05 2009-02-04 Gangagen Inc Actividades antimicrobianas derivadas de fago.
JP5305615B2 (ja) * 2006-06-05 2013-10-02 株式会社Adeka メナキノンの新規生合成経路に関与するタンパク質の遺伝子群を利用したメナキノンの製造方法
SG162834A1 (en) * 2006-07-14 2010-07-29 Genentech Inc Refolding of recombinant proteins
HUE037162T2 (hu) * 2007-07-09 2018-08-28 Genentech Inc Diszulfidkötés redukciójának megelõzése polipeptidek rekombináns elõállítása során
CN101665798B (zh) * 2008-09-06 2012-11-21 浙江我武生物科技股份有限公司 一种制备重组人血清白蛋白与干扰素α融合蛋白的方法
CN101503470A (zh) * 2008-09-27 2009-08-12 上海交通大学 rhDSL重组蛋白及其制备方法
JP2010088387A (ja) * 2008-10-10 2010-04-22 Waseda Univ 放線菌内で目的タンパク質を誘導発現可能なプロモーター

Also Published As

Publication number Publication date
RU2636353C2 (ru) 2017-11-22
BR112014023176B1 (pt) 2021-09-28
US20250137027A1 (en) 2025-05-01
CN109880867A (zh) 2019-06-14
CN104350156A (zh) 2015-02-11
US20240158825A1 (en) 2024-05-16
MX365947B (es) 2019-06-19
RU2017139267A (ru) 2019-02-12
SG10201912877SA (en) 2020-02-27
KR20140148392A (ko) 2014-12-31
KR20200037425A (ko) 2020-04-08
EP2831261A1 (en) 2015-02-04
MX2019007032A (es) 2019-08-16
CA3086730A1 (en) 2013-10-03
JP2018046825A (ja) 2018-03-29
HK1207120A1 (en) 2016-01-22
JP2020202849A (ja) 2020-12-24
ES2654424T3 (es) 2018-02-13
JP2019141049A (ja) 2019-08-29
RU2014137554A (ru) 2016-05-20
IL234377B (en) 2021-01-31
CN104350156B (zh) 2019-04-02
SI2831261T1 (en) 2018-01-31
US20150225760A1 (en) 2015-08-13
AU2017202484B2 (en) 2019-06-13
KR102096678B1 (ko) 2020-04-02
CA2866753A1 (en) 2013-10-03
SG11201406112TA (en) 2014-10-30
HRP20171966T1 (hr) 2018-02-09
AU2017202484A1 (en) 2017-05-04
MY171729A (en) 2019-10-25
SG10201508420VA (en) 2015-11-27
US20200199639A1 (en) 2020-06-25
AU2019226192A1 (en) 2019-09-26
JP6225162B2 (ja) 2017-11-01
CA2866753C (en) 2020-09-22
AR090340A1 (es) 2014-11-05
WO2013148249A1 (en) 2013-10-03
MX2014011558A (es) 2014-11-14
US20140080180A1 (en) 2014-03-20
US20160130624A1 (en) 2016-05-12
PL2831261T3 (pl) 2018-04-30
EP2831261B1 (en) 2017-10-18
BR112014023176A2 (pt) 2017-06-20
ZA201406434B (en) 2017-08-30
JP2015512259A (ja) 2015-04-27
US20230069966A1 (en) 2023-03-09
US20180291411A1 (en) 2018-10-11
MX2018007677A (es) 2020-11-12
AR116615A2 (es) 2021-05-26
AU2013240280A1 (en) 2014-10-16
US9765379B2 (en) 2017-09-19
US20210171997A1 (en) 2021-06-10

Similar Documents

Publication Publication Date Title
HRP20190454T1 (hr) Rekombinantni faktor viii proteini
SG11201400432VA (en) Polypeptide vaccine
ZA201406434B (en) Improved harvest operations for recombinant proteins
IL235041B (en) Recombinant bacterial host cell for protein expression
GB201304973D0 (en) Recombinant protein
HUE050164T2 (hu) Új négy-CTL epitóp-kapcsolt peptid
SG11201500457RA (en) Novel protein material
SG10201507721SA (en) CHO-GMT Recombinant Protein Expression
PL2851083T3 (pl) Kompozycja białkowa odporna na sterylizację promieniowaniem
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201204868D0 (en) Peptides
IL235052A0 (en) A method for increasing the secretion of recombinant proteins
GB201223114D0 (en) Novel peptide
IL235840A0 (en) Alternaria peptides
GB201213672D0 (en) Protein
SG11201500445SA (en) Novel protein material
SG11201504096RA (en) Recombinant protein
GB201210286D0 (en) Recombinant polypeptide
GB201215901D0 (en) Protein modification
GB201106130D0 (en) Polypeptide
GB201112985D0 (en) Polypeptide
GB201112849D0 (en) Polypeptide
GB201200743D0 (en) Protein bridges
GB201220328D0 (en) Peptides
GB201103169D0 (en) Protein expression